vs
SS Innovations International, Inc.（SSII）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
SS Innovations International, Inc.的季度营收约是TriSalus Life Sciences, Inc.的1.1倍（$14.5M vs $13.2M），SS Innovations International, Inc.净利率更高（-17.0% vs -73.9%，领先56.9%），SS Innovations International, Inc.同比增速更快（79.1% vs 59.8%），TriSalus Life Sciences, Inc.自由现金流更多（$-2.5M vs $-3.2M），过去两年SS Innovations International, Inc.的营收复合增速更高（99.9% vs 43.0%）
SS Innovations International, Inc.是一家全球化医疗科技企业，专注于研发、生产创新型外科手术机器人系统，为多地区医疗机构提供高精度、易获取的微创手术机器人平台，致力于提升手术效果、减轻手术操作负担。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
SSII vs TLSI — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.5M | $13.2M |
| 净利润 | $-2.5M | $-9.8M |
| 毛利率 | 43.9% | 86.7% |
| 营业利润率 | -3.7% | -24.8% |
| 净利率 | -17.0% | -73.9% |
| 营收同比 | 79.1% | 59.8% |
| 净利润同比 | -28.5% | 3.5% |
| 每股收益（稀释后） | $-0.01 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $14.5M | $13.2M | ||
| Q3 25 | $12.8M | $11.6M | ||
| Q2 25 | $10.0M | $11.2M | ||
| Q1 25 | $5.1M | $9.2M | ||
| Q4 24 | $8.1M | $8.3M | ||
| Q3 24 | $4.4M | $7.3M | ||
| Q2 24 | $4.5M | $7.4M | ||
| Q1 24 | $3.6M | $6.5M |
| Q4 25 | $-2.5M | $-9.8M | ||
| Q3 25 | $-3.7M | $-10.8M | ||
| Q2 25 | $-256.7K | $-8.3M | ||
| Q1 25 | $-5.7M | $-10.4M | ||
| Q4 24 | $-1.9M | $-10.1M | ||
| Q3 24 | $-3.2M | $-2.4M | ||
| Q2 24 | $-4.1M | $-4.3M | ||
| Q1 24 | $-9.8M | $-13.2M |
| Q4 25 | 43.9% | 86.7% | ||
| Q3 25 | 48.1% | 83.5% | ||
| Q2 25 | 59.1% | 83.9% | ||
| Q1 25 | 21.2% | 83.7% | ||
| Q4 24 | 48.9% | 85.3% | ||
| Q3 24 | 52.8% | 86.3% | ||
| Q2 24 | 31.9% | 87.6% | ||
| Q1 24 | 20.0% | 85.0% |
| Q4 25 | -3.7% | -24.8% | ||
| Q3 25 | -14.3% | -77.9% | ||
| Q2 25 | 1.0% | -65.4% | ||
| Q1 25 | -115.6% | -79.9% | ||
| Q4 24 | -22.7% | -91.8% | ||
| Q3 24 | -73.1% | -118.9% | ||
| Q2 24 | -90.9% | -111.0% | ||
| Q1 24 | -270.3% | -180.8% |
| Q4 25 | -17.0% | -73.9% | ||
| Q3 25 | -29.0% | -93.5% | ||
| Q2 25 | -2.6% | -73.9% | ||
| Q1 25 | -111.0% | -113.2% | ||
| Q4 24 | -23.7% | -122.4% | ||
| Q3 24 | -74.0% | -32.6% | ||
| Q2 24 | -91.8% | -58.8% | ||
| Q1 24 | -270.5% | -204.5% |
| Q4 25 | $-0.01 | $-0.22 | ||
| Q3 25 | $-0.02 | $-0.96 | ||
| Q2 25 | $0.00 | $-0.27 | ||
| Q1 25 | $-0.03 | $-0.39 | ||
| Q4 24 | $-0.01 | $-0.38 | ||
| Q3 24 | $-0.02 | $-0.12 | ||
| Q2 24 | $-0.02 | $-0.21 | ||
| Q1 24 | $-0.06 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.2M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $38.2M | $-33.9M |
| 总资产 | $74.2M | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $3.2M | $20.4M | ||
| Q3 25 | $5.7M | $22.7M | ||
| Q2 25 | $11.4M | $26.5M | ||
| Q1 25 | $15.9M | $13.0M | ||
| Q4 24 | $466.5K | $8.5M | ||
| Q3 24 | $220.4K | $11.3M | ||
| Q2 24 | $608.2K | $16.5M | ||
| Q1 24 | $948.1K | $4.0M |
| Q4 25 | $38.2M | $-33.9M | ||
| Q3 25 | $39.6M | $-26.7M | ||
| Q2 25 | $42.0M | $-19.4M | ||
| Q1 25 | $40.6M | $-34.4M | ||
| Q4 24 | $13.5M | $-25.9M | ||
| Q3 24 | $13.7M | $-20.4M | ||
| Q2 24 | $14.8M | $-25.3M | ||
| Q1 24 | $16.7M | $-36.0M |
| Q4 25 | $74.2M | $35.3M | ||
| Q3 25 | $69.6M | $36.5M | ||
| Q2 25 | $70.0M | $41.3M | ||
| Q1 25 | $63.5M | $28.6M | ||
| Q4 24 | $42.4M | $24.0M | ||
| Q3 24 | $39.0M | $27.5M | ||
| Q2 24 | $35.7M | $32.4M | ||
| Q1 24 | $35.2M | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.5M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $-3.2M | $-2.5M |
| 自由现金流率自由现金流/营收 | -22.3% | -19.1% |
| 资本支出强度资本支出/营收 | 11.8% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-22.2M | $-19.1M |
8季度趋势，按日历期对齐
| Q4 25 | $-1.5M | $-2.5M | ||
| Q3 25 | $-7.5M | $-3.7M | ||
| Q2 25 | $-3.5M | $-7.3M | ||
| Q1 25 | $-6.1M | $-4.5M | ||
| Q4 24 | $-3.3M | $-5.7M | ||
| Q3 24 | $-2.5M | $-10.8M | ||
| Q2 24 | $-1.0M | $-13.4M | ||
| Q1 24 | $-2.7M | $-10.9M |
| Q4 25 | $-3.2M | $-2.5M | ||
| Q3 25 | $-8.2M | $-3.9M | ||
| Q2 25 | $-3.8M | $-7.4M | ||
| Q1 25 | $-7.0M | $-5.3M | ||
| Q4 24 | $-3.4M | $-5.8M | ||
| Q3 24 | $-4.2M | $-11.0M | ||
| Q2 24 | $-3.1M | $-13.5M | ||
| Q1 24 | $-2.8M | $-10.9M |
| Q4 25 | -22.3% | -19.1% | ||
| Q3 25 | -64.1% | -33.9% | ||
| Q2 25 | -37.7% | -66.1% | ||
| Q1 25 | -136.2% | -57.3% | ||
| Q4 24 | -41.7% | -69.7% | ||
| Q3 24 | -96.9% | -149.9% | ||
| Q2 24 | -69.5% | -183.1% | ||
| Q1 24 | -76.9% | -169.3% |
| Q4 25 | 11.8% | 0.3% | ||
| Q3 25 | 5.9% | 1.9% | ||
| Q2 25 | 3.2% | 0.8% | ||
| Q1 25 | 17.0% | 8.2% | ||
| Q4 24 | 1.5% | 0.6% | ||
| Q3 24 | 38.8% | 2.3% | ||
| Q2 24 | 46.8% | 0.8% | ||
| Q1 24 | 3.5% | 1.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SSII
| System Sales | $13.4M | 92% |
| Other | $1.2M | 8% |
TLSI
暂无分部数据
